What it means for a patient
- This paper is about injectable fillers, not face lift surgery.
- It describes a planning method, not a proven treatment result.
- The first stage used a polycaprolactone mixture off-label, meaning outside its approved use.
- Limits: one case, short follow-up, no measured outcomes, and the author states the framework is unproven.
Why this paper matters
It offers a planning language for filler contouring based on anatomy and cannula paths. The author presents it for clinical planning and education, not as evidence of effect.
Overview
Facial filler contouring is usually planned around product choice and adding volume to one area at a time. The author proposes a design-first framework built on anatomy specific to Northeast Asian faces. It is illustrated with one two-stage clinical case and 15 supplementary cases.
Findings
- The framework puts whole-face contour continuity and anatomically appropriate pathways ahead of isolated volume correction.
- A "Reference Facial Form" serves as a qualitative design reference, translated into geometric principles and then into predefined vectors.
- Vectors are planned cannula paths with set entry points, directions, withdrawal paths and deep anatomical planes.
- Planning is guided by entry points, vector direction and relative filler distribution, rather than fixed injection volumes.
- One two-stage case: first an off-label diluted polycaprolactone-based mixture for deep structural support, then hyaluronic acid filler for contour refinement after stabilization.
- Early images showed the planned vectors matched early contour change, but were not suitable for establishing efficacy or durability.
- Follow-up was not long enough to establish long-term safety.
- 15 de-identified supplementary cases showed repeated vector and entry-point patterns; they were not analyzed as an outcome group.
- Efficacy, reproducibility between injectors, generalizability and long-term safety need larger studies.
Terms
- Filler contouring: shaping the face with injected filler material.
- Cannula: a thin, blunt-tipped tube used to place filler.
- Vector: here, a planned path for the cannula, with a set entry point and direction.
- Polycaprolactone: a dissolvable material used in some injectable products; here diluted and mixed.
- Hyaluronic acid filler: a gel filler made from a sugar molecule found naturally in skin.
- Off-label: use of a product in a way its approval does not cover.
- Deep plane: here, a deeper tissue layer where filler is placed for structural support.